Brentuximab vedotin is an effective therapy for CD30+
mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?
2017 ◽
Vol 177
(6)
◽
pp. 1474-1475
◽
2020 ◽
2015 ◽
Vol 95
(3)
◽
pp. 359-369
◽
2019 ◽
Vol 61
(1)
◽
pp. 176-180
◽
2013 ◽
Vol 13
(4)
◽
pp. 493-495
◽
Keyword(s):
Keyword(s):